Early glycaemic control among patients with type 2 diabetes and initial glucose‐lowering treatment: a 13‐year population‐based cohort study
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aim: To examine real‐life time trends in early glycaemic control in patients with type 2 diabetes between 2000 and 2012. Methods: We used population‐based medical databases to ascertain the association between achievement of glycaemic control with initial glucose‐lowering treatment in patients with incident type 2 diabetes in N orthern D enmark. Success in reaching glycated haemoglobin ( HbA1c ) goals within 3–6 months was examined using regression analysis. Results: Of 38 418 patients, 91% started with oral glucose‐lowering drugs in monotherapy. Metformin initiation increased from 32% in 2000–2003 to 90% of all patients in 2010–2012. Pretreatment (interquartile range) HbA1c levels decreased from 8.9 (7.6–10.7)% in 2000–2003 to 7.0 (6.5–8.1)% in 2010–2012. More patients achieved an HbA1c target of <7% (<53 mmol/mol) in 2010–2012 than in 2000–2003 [80 vs 60%, adjusted relative risk ( aRR ) 1.10, 95% confidence interval ( CI ) 1.08–1.13], and more achieved an HbA1c target of <6.5% [(<48 mmol/mol) 53 vs 37%, aRR 1.07 95% CI 1.03–1.11)], with similar success rates observed among patients aged <65 years without comorbidities. Achieved HbA1c levels were similar for different initiation therapies, with reductions of 0.8% (from 7.3 to 6.5%) on metformin, 1.5% (from 8.1 to 6.6%) on sulphonylurea, 4.0% (from 10.4 to 6.4%) on non‐insulin combination therapies, and 3.8% (from 10.3 to 6.5%) on insulin monotherapy. Conclusions: Pretreatment HbA1c levels in patients with incident type 2 diabetes have decreased substantially, which is probably related to earlier detection and treatment in accordance with changing guidelines. Achievement of glycaemic control has improved, but 20% of patients still do not attain an HbA1c level of <7% within the first 6 months of initial treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968 · cited 1×
“The Aarhus University Prescription Database contains complete information on all prescriptions dispensed at community pharmacies for every resident, with complete coverage from 1998 onwards [21].”
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749 · cited 1×
“As lower comorbidity and lower pretreatment HbA1c at diagnosis may well reflect improved diabetes care over the last decade [35], both crude and adjusted RRs for HbA1c attainment by calendar time are important to assess when evaluating clinical quality.”
BackgroundEkström, N., Schiöler, L., Svensson, A.-M., Eeg-Olofsson, K., Miao Jonasson, J., Zethelius, B., Cederholm, J., Eliasson, B., & Gudbjörnsdottir, S. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001076 · Cited by 221
Cited by
The changing face of diabetes complications
Gregg, E. W., Sattar, N., & Ali, M. K. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30010-9 · Cited by 612
Gylfadottir, S. S., Christensen, D. H., Nicolaisen, S. K., Andersen, H., Callaghan, B. C., Itani, M., Khan, K. S., Kristensen, A. G., Nielsen, J. S., Sindrup, S. H., et al. (2020) · Pain · doi:10.1097/j.pain.0000000000001744 · Cited by 151
“However, baseline data from the DD2 cohort are similar to data from a cohort of type 2 patients receiving their first glucose-lowering drug indicating that the DD2 cohort is representative of recently diagnosed type 2 diabetes patients in Denmark.10,36 The cross-sectional design of this study has some innate limitatio…”
ResultInfluentialSelf-citationSvensson, E., Baggesen, L. M., Johnsen, S. P., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Thomsen, R. W. (2017) · Diabetes Care · doi:10.2337/dc16-2271 · Cited by 77
“Pretreatment HbA1c levels have decreased substantially over time in Denmark and in other countries, and achievement of early glycemic control has improved (22).”
BackgroundMethodSelf-citationCatalog of 199 register-based definitions of chronic conditions
Hvidberg, M. F., Johnsen, S. P., Glümer, C., Petersen, K. D., Olesen, A. V., & Ehlers, L. (2016) · Scandinavian Journal of Public Health · doi:10.1177/1403494816641553 · Cited by 63
“[39] Thomsen RW, baggesen LM, Svensson E, et al.”
BackgroundSelf-citationThomsen, R. W., Baggesen, L. M., Søgaard, M., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Johnsen, S. P. (2015) · Diabetologia · doi:10.1007/s00125-015-3698-1 · Cited by 32
Self-citation
Metadata
- Authors
- Thomsen, R. W., Baggesen, L. M., Svensson, E., Pedersen, L., Nørrelund, H., Buhl, E. S., Haase, C. L., & Johnsen, S. P.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2015-06-08
- Volume
- 17
- Issue
- 8
- Pages
- 771-780
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W1753660045
- Cited by
- 38
- References
- 3
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.